MERS-CoV‒Specific T-Cell Responses in Camels after Single MVA-MERS-S Vaccination.
- Resource Type
- Academic Journal
- Authors
- Meyer Zu Natrup C; Schünemann LM; Saletti G; Clever S; Herder V; Joseph S; Rodriguez M; Wernery U; Sutter G; Volz A
- Source
- Publisher: National Center for Infectious Diseases, Centers for Disease Control and Prevention (CDC) Country of Publication: United States NLM ID: 9508155 Publication Model: Print Cited Medium: Internet ISSN: 1080-6059 (Electronic) Linking ISSN: 10806040 NLM ISO Abbreviation: Emerg Infect Dis Subsets: MEDLINE
- Subject
- Language
- English
We developed an ELISPOT assay for evaluating Middle East respiratory syndrome coronavirus (MERS-CoV)‒specific T-cell responses in dromedary camels. After single modified vaccinia virus Ankara-MERS-S vaccination, seropositive camels showed increased levels of MERS-CoV‒specific T cells and antibodies, indicating suitability of camel vaccinations in disease-endemic areas as a promising approach to control infection.